These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 23322571

  • 1. Oxidized porous silicon particles covalently grafted with daunorubicin as a sustained intraocular drug delivery system.
    Chhablani J, Nieto A, Hou H, Wu EC, Freeman WR, Sailor MJ, Cheng L.
    Invest Ophthalmol Vis Sci; 2013 Feb 01; 54(2):1268-79. PubMed ID: 23322571
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Hydrosilylated porous silicon particles function as an intravitreal drug delivery system for daunorubicin.
    Hartmann KI, Nieto A, Wu EC, Freeman WR, Kim JS, Chhablani J, Sailor MJ, Cheng L.
    J Ocul Pharmacol Ther; 2013 Jun 01; 29(5):493-500. PubMed ID: 23448595
    [Abstract] [Full Text] [Related]

  • 4. A sustained dual drug delivery system for proliferative vitreoretinopathy.
    Xiao Y, Choi KS, Warther D, Huffman K, Landeros S, Freeman WR, Sailor MJ, Cheng L.
    Drug Deliv; 2020 Dec 01; 27(1):1461-1473. PubMed ID: 33100053
    [Abstract] [Full Text] [Related]

  • 5. Controlled Release of Dexamethasone From an Intravitreal Delivery System Using Porous Silicon Dioxide.
    Hou H, Wang C, Nan K, Freeman WR, Sailor MJ, Cheng L.
    Invest Ophthalmol Vis Sci; 2016 Feb 01; 57(2):557-66. PubMed ID: 26882530
    [Abstract] [Full Text] [Related]

  • 6. A Novel Approach of Daunorubicin Application on Formation of Proliferative Retinopathy Using a Porous Silicon Controlled Delivery System: Pharmacodynamics.
    Hou H, Huffman K, Rios S, Freeman WR, Sailor MJ, Cheng L.
    Invest Ophthalmol Vis Sci; 2015 Apr 01; 56(4):2755-63. PubMed ID: 25829415
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Intravitreal controlled release of dexamethasone from engineered microparticles of porous silicon dioxide.
    Wang C, Hou H, Nan K, Sailor MJ, Freeman WR, Cheng L.
    Exp Eye Res; 2014 Dec 01; 129():74-82. PubMed ID: 25446320
    [Abstract] [Full Text] [Related]

  • 9. Surface engineering of porous silicon microparticles for intravitreal sustained delivery of rapamycin.
    Nieto A, Hou H, Moon SW, Sailor MJ, Freeman WR, Cheng L.
    Invest Ophthalmol Vis Sci; 2015 Jan 22; 56(2):1070-80. PubMed ID: 25613937
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Intravitreal properties of porous silicon photonic crystals: a potential self-reporting intraocular drug-delivery vehicle.
    Cheng L, Anglin E, Cunin F, Kim D, Sailor MJ, Falkenstein I, Tammewar A, Freeman WR.
    Br J Ophthalmol; 2008 May 22; 92(5):705-11. PubMed ID: 18441177
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A preliminary evaluation of dexamethasone palmitate emulsion: a novel intravitreal sustained delivery of corticosteroid for treatment of macular edema.
    Daull P, Paterson CA, Kuppermann BD, Garrigue JS.
    J Ocul Pharmacol Ther; 2013 Mar 22; 29(2):258-69. PubMed ID: 23331052
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.